Edition:
India

Shilpa Medicare Gets U.S. FDA Tentative Nod For ANDA, Bortezomid For Injection, 3.5Mg/Vial


Tuesday, 9 Apr 2019 

April 9 (Reuters) - Shilpa Medicare Ltd ::GETS U.S. FDA TENTATIVE APPROVAL FOR ITS ANDA, BORTEZOMID FOR INJECTION, 3.5MG/VIAL. 

Related Company News

Company Quote

260.2
-8.2 -3.06%
2:43pm IST